• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剖析原发性和转移性口咽鳞状细胞癌中组织隔室特异性蛋白质特征

Dissecting Tissue Compartment-Specific Protein Signatures in Primary and Metastatic Oropharyngeal Squamous Cell Carcinomas.

作者信息

Sadeghirad Habib, Monkman James, Mehdi Ahmed M, Ladwa Rahul, O'Byrne Ken, Hughes Brett G M, Kulasinghe Arutha

机构信息

The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia.

Queensland Cyber Infrastructure Foundation Ltd., QCIF Facility for Advanced Bioinformatics, Brisbane, QLD, Australia.

出版信息

Front Immunol. 2022 May 16;13:895513. doi: 10.3389/fimmu.2022.895513. eCollection 2022.

DOI:10.3389/fimmu.2022.895513
PMID:35651606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9149425/
Abstract

Head and neck squamous cell carcinoma (HNSCC) often presents with locoregional or distant disease, despite multimodal therapeutic approaches, which include surgical resection, chemoradiotherapy, and more recently, immunotherapy for metastatic or recurrent HNSCC. Therapies often target the primary and nodal regional HNSCC sites, and their efficacy at controlling occult distant sites remains poor. While our understanding of the tumor microenvironment conducive to effective therapies is increasing, the biology underpinning locoregional sites remains unclear. Here, we applied targeted spatial proteomic approaches to primary and lymph node metastasis from an oropharyngeal SCC (OPSCC) cohort to understand the expression of proteins within tumors, and stromal compartments of the respective sites in samples of both matched and unmatched patients. In unmatched analyses of n = 43 primary and 11 nodal metastases, our data indicated that tumor cells in nodal metastases had higher levels of Ki-67, PARP, BAD, and cleaved caspase 9, suggesting a role for increased proliferation, DNA repair, and apoptosis within these metastatic cells. Conversely, in matched analyses (n = 7), pro-apoptotic markers BIM and BAD were enriched in the stroma of primary tumors. Univariate, overall survival (OS) analysis indicated CD25 in tumor regions of primary tumors to be associated with reduced survival (HR = 3.3, p = 0.003), while progesterone receptor (PR) was associated with an improved OS (HR = 0.33, p = 0.015). This study highlights the utility of spatial proteomics for delineating the tumor and stromal compartment composition, and utility toward understanding these properties in locoregional metastasis. These findings indicate unique biological properties of lymph node metastases that may elucidate further understanding of distant metastatic in OPSCC.

摘要

头颈部鳞状细胞癌(HNSCC)尽管采用了多模式治疗方法,包括手术切除、放化疗,以及最近用于转移性或复发性HNSCC的免疫治疗,但仍常出现局部区域或远处疾病。治疗通常针对原发性和淋巴结区域的HNSCC部位,而它们在控制隐匿性远处部位方面的疗效仍然很差。虽然我们对有利于有效治疗的肿瘤微环境的理解在不断增加,但局部区域部位的生物学基础仍不清楚。在这里,我们对头颈部鳞状细胞癌(OPSCC)队列中的原发性肿瘤和淋巴结转移灶应用靶向空间蛋白质组学方法,以了解肿瘤内蛋白质的表达,以及匹配和不匹配患者样本中各部位的基质区室。在对43例原发性肿瘤和11例淋巴结转移灶的非匹配分析中,我们的数据表明,淋巴结转移灶中的肿瘤细胞具有较高水平的Ki-67、PARP、BAD和裂解的半胱天冬酶9,这表明这些转移细胞内的增殖、DNA修复和凋亡增加。相反,在匹配分析(n = 7)中,促凋亡标志物BIM和BAD在原发性肿瘤的基质中富集。单变量总体生存(OS)分析表明,原发性肿瘤肿瘤区域中的CD25与生存率降低相关(HR = 3.3,p = 0.003),而孕激素受体(PR)与OS改善相关(HR = 0.33,p = 0.015)。本研究强调了空间蛋白质组学在描绘肿瘤和基质区室组成方面的实用性,以及在理解局部区域转移中的这些特性方面的实用性。这些发现表明了淋巴结转移的独特生物学特性,这可能有助于进一步了解口咽鳞状细胞癌中的远处转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/c129835b4f95/fimmu-13-895513-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/2684508c035d/fimmu-13-895513-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/5b2f581a3753/fimmu-13-895513-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/96b687ac27b5/fimmu-13-895513-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/cbded14c2307/fimmu-13-895513-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/c129835b4f95/fimmu-13-895513-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/2684508c035d/fimmu-13-895513-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/5b2f581a3753/fimmu-13-895513-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/96b687ac27b5/fimmu-13-895513-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/cbded14c2307/fimmu-13-895513-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a12/9149425/c129835b4f95/fimmu-13-895513-g005.jpg

相似文献

1
Dissecting Tissue Compartment-Specific Protein Signatures in Primary and Metastatic Oropharyngeal Squamous Cell Carcinomas.剖析原发性和转移性口咽鳞状细胞癌中组织隔室特异性蛋白质特征
Front Immunol. 2022 May 16;13:895513. doi: 10.3389/fimmu.2022.895513. eCollection 2022.
2
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.转移性和复发性头颈部鳞状细胞癌的基因图谱
J Clin Invest. 2016 Jan;126(1):169-80. doi: 10.1172/JCI82066. Epub 2015 Nov 30.
3
Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.手术挽救治疗可提高人乳头瘤病毒(HPV)阳性和HPV阴性的复发性局部区域及远处转移性口咽癌患者的总生存率。
Cancer. 2015 Jun 15;121(12):1977-84. doi: 10.1002/cncr.29323. Epub 2015 Mar 17.
4
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.头颈部鳞状细胞癌肿瘤微环境的分区空间分析鉴定出免疫检查点分子和肿瘤坏死因子受体超家族成员作为免疫治疗反应的生物标志物。
Front Immunol. 2023 Apr 3;14:1135489. doi: 10.3389/fimmu.2023.1135489. eCollection 2023.
5
Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.口咽鳞状细胞癌局部区域和远处转移的分子预测因子。
J Otolaryngol Head Neck Surg. 2013 Oct 16;42(1):53. doi: 10.1186/1916-0216-42-53.
6
[Analyses of clinicopathologic factors affecting neck control after postoperative radiation as adjuvant treatment for lymph node metastasis in head and neck squamous cell carcinoma].[影响头颈部鳞状细胞癌淋巴结转移术后放疗作为辅助治疗后颈部控制的临床病理因素分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Jul 7;51(7):485-90. doi: 10.3760/cma.j.issn.1673-0860.2016.07.002.
7
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.采用现代放射技术治疗后,局部晚期头颈部鳞状细胞癌患者的治疗失败模式和复发后结局。
JAMA Oncol. 2017 Nov 1;3(11):1487-1494. doi: 10.1001/jamaoncol.2017.0973.
8
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
9
Occult nodal metastasis in head and neck carcinoma patients treated with chemoradiotherapy.头颈部癌患者接受放化疗后的隐匿性淋巴结转移。
Am J Otolaryngol. 2022 Mar-Apr;43(2):103361. doi: 10.1016/j.amjoto.2021.103361. Epub 2021 Dec 24.
10
Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.头颈部癌症 N3 颈淋巴结转移患者的生存结果。
Clin Otolaryngol. 2020 May;45(3):342-349. doi: 10.1111/coa.13501. Epub 2020 Feb 20.

引用本文的文献

1
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response.头颈部癌症中三级淋巴滤泡的空间动态:免疫治疗反应的见解。
J Transl Med. 2024 Jul 24;22(1):677. doi: 10.1186/s12967-024-05409-y.
2
Mapping cancer biology in space: applications and perspectives on spatial omics for oncology.在空间中绘制癌症生物学图谱:空间组学在肿瘤学中的应用和展望。
Mol Cancer. 2024 Jan 30;23(1):26. doi: 10.1186/s12943-024-01941-z.
3
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.

本文引用的文献

1
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors.免疫检查点抑制剂时代的口咽鳞状细胞癌治疗。
Viruses. 2021 Jun 25;13(7):1234. doi: 10.3390/v13071234.
2
Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients.头颈部鳞状细胞癌患者肿瘤微环境的高度多重数字空间分析
Front Oncol. 2021 Jan 19;10:607349. doi: 10.3389/fonc.2020.607349. eCollection 2020.
3
Understanding the tumor microenvironment for effective immunotherapy.理解肿瘤微环境以实现有效的免疫治疗。
头颈部鳞状细胞癌肿瘤微环境的分区空间分析鉴定出免疫检查点分子和肿瘤坏死因子受体超家族成员作为免疫治疗反应的生物标志物。
Front Immunol. 2023 Apr 3;14:1135489. doi: 10.3389/fimmu.2023.1135489. eCollection 2023.
Med Res Rev. 2021 May;41(3):1474-1498. doi: 10.1002/med.21765. Epub 2020 Dec 4.
4
The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies.免疫肿瘤学中预测性生物标志物的发展态势,重点关注空间技术。
Clin Transl Immunology. 2020 Nov 22;9(11):e1215. doi: 10.1002/cti2.1215. eCollection 2020.
5
Head and neck squamous cell carcinoma.头颈部鳞状细胞癌
Nat Rev Dis Primers. 2020 Nov 26;6(1):92. doi: 10.1038/s41572-020-00224-3.
6
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7).癌症免疫治疗的新新兴靶点:CD27(TNFRSF7)。
ESMO Open. 2020 Mar;4(Suppl 3):e000629. doi: 10.1136/esmoopen-2019-000629.
7
Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region.咀嚼槟榔地区口咽鳞状细胞癌的临床特征及治疗结果。
Sci Rep. 2020 Jan 16;10(1):526. doi: 10.1038/s41598-019-57177-1.
8
Head and Neck Cancer.头颈癌
N Engl J Med. 2020 Jan 2;382(1):60-72. doi: 10.1056/NEJMra1715715.
9
Identification of responders to immune checkpoint therapy: which biomarkers have the highest value?免疫检查点治疗应答者的识别:哪种生物标志物价值最高?
J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:52-56. doi: 10.1111/jdv.15992.
10
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.BAD 通路的表达是三阴性状态和不良预后的标志物。
Sci Rep. 2019 Nov 25;9(1):17496. doi: 10.1038/s41598-019-53695-0.